Alex Denner (Mark Neuling/CNBC/NBCU Photo Bank via Getty Images)

Alex Den­ner's firm takes over Amarin, ousts non-Saris­sa board mem­bers

Ac­tivist in­vestor Alex Den­ner has now so­lid­i­fied his con­trol over Irish drug­mak­er Amarin.

In the wake of last week’s share­hold­er elec­tion that saw Den­ner’s VC Saris­sa Cap­i­tal Man­age­ment in­stall sev­en di­rec­tors on Amarin’s board, the com­pa­ny an­nounced Mon­day af­ter­noon that the sev­en non-Saris­sa board mem­bers are ex­it­ing from their po­si­tions “to avoid fur­ther proxy con­tests.”

Mur­ray Stew­art, a for­mer CMO at GSK who was added to Amarin’s board just ear­li­er this year and was a cat­a­lyst that led to the vote, is al­so leav­ing the board.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.